siRNA分子非病毒纳米传递载体的研究进展
作者：徐元龙;朱卫;李学明;韦萍;
Author：
收稿日期： 年卷（期）页码：2012,27(01):-106-110
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：小分子干扰RNA;非病毒;纳米载体;传递
Key words：
基金项目：江苏省自然科学基金资助项目(编号:09JKB350001)
中文摘要
小分子干扰RNA(siRNA)的非病毒纳米传递载体与病毒载体比较,前者具有简便、安全和毒性小等特点,易于为临床所接受,因此近年的研究进展迅速。文中根据最近几年来国内外相关文献,对siRNA非病毒纳米传递载体的研究进行了综述。
参考文献
[1]Reischl D,Zimmer A.Drug delivery of siRNA therapeutics:potentials and limits of nanosystems[J].Nanomedicine:nano-technology,Biology and Medicine,2009,5(1):8-20.
[2]David S,Bruno P,Beno JP,et al.Non-viral nanosystems forsystemic siRNA delivery[J].Pharmacological Res,2010,62(2):100-114.
[3]Melanie W,Kirstin C,Michael H,et al.Small interfering RNA(siRNA)delivery into murine bone marrow-derived macropha-ges by electroporation[J].J Immunological Methods,2010,353(1-2):102-110.
[4]邵荣光.小干扰RNA介导的多靶点肿瘤治疗[J].药学学报,2009,44(3):219-225.
[5]Keller M.Nanomedicinal delivery approaches for therapeutic siR-NA[J].International J Pharmaceutics,2009,379(2):210-211.
[6]Zimmermann TS,Lee AC,Akinc A,et al.RNAi-mediatedgene silencing in non-human primates[J].Nature,2006,441(7089):111-114.
[7]Morrissey DV,Lockridge JA,Shaw L,et al.Potent and persis-tent in vivo anti-HBV activity of chemically modified siRNAs[J].Nature Biotechnol,2005,23(8):1002-1007.
[8]Morrissey DV,Blanchard K,Shaw L,et al.Activity of stabilizedshort interfering RNA in a mouse model of hepatitis B virus rep-lication[J].Hepatology,2005,41(13):49-56.
[9]Peer D,Park EJ,Morishita Y,et al.Systemic leukocyte directedsiRNA delivery revealing cyclin D1 as an anti-inflammatorytarget[J].Science,2008,319(5863):627-630.
[10]Marie M,Catherine P,Arnaud V,et al.Progress in developingcationic vectors for non-viral systemic gene therapy againstcancer[J].Biomaterials,2008,29(24-25):3477-3496.
[11]Ma Z,Li J,He F,et al.Cationic lipids enhance siRNA-media-ted interferon response in mice[J].Biochem Biophys Res Com-mun,2005,330(3):755-759.
[12]Pirollo KF,Rait A,Zhou Q,et al.Materializing the potential ofsmall interfering RNA via a tumor-targeting nanodelivery sys-tem[J].Cancer Res,2007,67(29):38-43.
[13]Khoury M,Louis-Plence P,Escriou V,et al.Efficient new cat-ionic liposome formulation for systemic delivery of small interfer-ing RNA silencing tumor necrosis factor alpha in experimentalarthritis[J].Arthritis Rheum,2006,54(18):67-77.
[14]Miyawaki-Shimizu K,Predescu D,Shimizu J,et al.siRNA-induced caveolin-1 knockdown in mice increases lung vascularpermeability via the junctional pathway[J].Am J Physiol LungCell Mol Physiol,2006,290(2):405-413.
[15]Akinc A,Goldberg M,Qin J,et al.Development of lipidoid-siRNA formulations for systemic delivery to the liver[J].MolTher,2009,17(87):2-9.
[16]Anna H,Micha K,Tadeusz L,et al.Polymer-based non-viralgene delivery as a concept for the treatment of cancer[J].Phar-macological/reports,2009,61(6):993-999.
[17]Kawata E,Ashihara E,Kimura S,et al.Administration ofPLK-1 small interfering RNA with atelocollagen prevents thegrowth of liver metastases of lung cancer[J].Mol Cancer Ther,2008,7(290):4-12.
[18]Naeyea B,Raemdoncka K,Remauta K,et al.PEGylation of bio-degradable dextran nanogels for siRNA delivery[J].Eur J Phar-maceutical Sci,2010,40(4):342-351.
[19]Hu-Lieskovan S,Heidel JD,Bartlett DW,et al.Sequence-specific knockdown of EWS-FLI1 by targeted,nonviral deliv-ery of small interfering RNA inhibits tumor growth in amurinemodel of metastatic Ewing's sarcoma[J].Cancer Res,2005,65(89):84-92.
[20]Patil Y,Panyam J.Polymeric nanoparticles for siRNA deliveryand gene silencing[J].Inter l J Pharmaceutics,2009,367(1-2):195-203.
[21]H de Martimprey,Vauthier a alvy.Polymer nanocarriers for thedelivery of small fragments of nucleic acids:Oligonucleotidesand siRNA[J].Euro J Pharmac Biopharmac,2009,71(3):490-504.
[22]Kim SH,Jeong JH,Lee SH,et al.Local and systemic delivery ofVEGF siRNA using polyelectrolyte complex micelles for effectivetreatment of cancer[J].J Control Release,2008,129(2):107-116.
[23]Wang JP,Feng SS,Wang S,et al.Evaluation of cationic nanop-articles of biodegradable copolymers as siRNA delivery systemfor hepatitis B treatment[J].Inter J Pharmac,2010,400(1-2):194-200
[24]Kumar P,Wu H,McBride JL,et al.Transvascular delivery ofsmall interfering RNA to the central nervous system[J].Na-ture,2007,448(7149):39-43.
[25]Peer D,Zhu P,Carman CV,et al.Selective gene silencing inactivated leukocytes by targeting siRNAs to the integrin lympho-cyte function associated antigen-1[J].Proc Natl Acad SciUSA,2007,104(40):5-100.
[26]Todd LK,Lu ZR.Targeted intracellular codelivery of chemothera-peutics and nucleic acid with a well-defined dendrimer-basednanoglobular carrier[J].Biomaterials,2009,30(29):5660-5666.
【关闭】
